DarioHealth (DRIO) Reports Q4 Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
DarioHealth Reports Fourth Quarter and Year End 2019 Results
March 17, 2020 6:30 AM EDTNEW YORK, March 17, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate and commercial update.
Transformed the business into a software as a service (SAAS)-based membership model with recurring revenues and potential for high margin profile Opened multiple channels within the business-to-business-to-consumer (B2B2C) marketplace laying the foundation for potential future growth with expected lower customer acquisition costs Produced additional... More